REFERENCES
- Hamann T., Scheuer P. J. J. Am. Chem. Soc. 1993; 115: 5825–5826
- Jimeno J. M., Faircloth G., Cameron L., Meely K., Vega E., Gómez A., Fernández Sousa-Faro J. M., Rinehart K. Drugs Future 1996; 21: 1155–1165
- Garcia-Rocha M., Bonay P., Avila J. Cancer Lett. 1996; 99: 43–50
- Supko J. G., Lu H. Clin. Cancer Res. 1999; 5: 3792s
- Faircloth G., Grant W., Smith B., Supko J., Brown A., Geldof A., Jimeno J. Proc. Am. Assoc. Cancer Res. 2000; 41: A3823
- EORTC New Drug Development Committee. Eur. J. Cancer Clin. Oncol. 1985; 21: 1005–1007
- Carpenter J. F., Pikal M. J., Chang B. S., Randolph T. W. Pharm. Res. 1997; 14: 969–975
- Powell M. F., Nguyen T., Baloian L. PDA J. Pharm. Sci. Technol. 1998; 52: 238–311
- Sweetana S., Akers M. J. PDA J. Pharm. Sci. Technol. 1996; 50: 330–342
- Johnston T. P. PDA J. Pharm. Sci. Technol. 1996; 50: 239–245
- Chang B. S., Kendrick B. S., Carpenter J. F. J. Pharm. Sci. 1996; 85: 1325–1330
- Haikala R., Eerola R., Tanninen V. P., Yliruusi J. PDA J. Pharm. Sci. Technol. 1997; 51: 96–101
- S-Matrix Corporation. Manual of CARD. S-Matrix Corporation, Eureka, CA 1995
- Lai M. C., Topp E. M. J. Pharm. Sci. 1999; 88: 489–500
- Skrabanja A. T.P., de Meere A. L.J., de Ruiter R. A., van den Oetelaar P. J.M. PDA. J. Pharm. Sci. Technol. 1994; 48: 311–317
- Pikal M. J., Dellerman K. M., Roy M. L., Riggin R. M. Pharm. Res. 1991; 8: 427–436
- Craig D. Q.M., Royall P. G., Kett V. L., Hopton M. L. Int. J. Pharm. 1999; 179: 179–207
- Nuijen B., Bouma M., Henrar R. E.C., Floriano P., Jimeno J. M., Talsma H., Kettenes-van den Bosch J. J., Heck A. J.R., Bult A., Beijnen J. H. PDA J. Pharm. Sci. Technol. 2000; 54: 193–208
- Kreilgaard L., Frokjaer S., Flink J. M., Randolph T. W., Carpenter J. F. J. Pharm. Sci. 1999; 88: 281–290
- Nannan Panday V. R., Huizing M. T., Ten Bokkel Huinink W. W., Vermorken J. B., Beijnen J. H. Clin. Drug Invest. 1998; 15: 327
- Huizing M. T., Giaccone G., van Warmerdam L. J.C., et al. J. Clin. Oncol. 1997; 15: 317
- Nuijen B., Bouma M., Henrar R. E.C., Manada C., Bult A., Beijnen J. H. Anti-Cancer Drugs 1999; 10: 879–887